More tools:Markets·Screener·Research·Chat

Akso Health Group ADS (AHG) Financial Statements

Akso Health Group ADS
SIC 7389 · SERVICES-BUSINESS SERVICES, NEC
FIGI BBG00HVQFN03
XNAS · usd
0.82▼ 0.03 (-3.68%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value—
Trailing P/E—
Price / Sales
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt—
Trading Information
Previous Close0.85
Day's Range0.80 – 0.90
52-Week Range0.80 – 2.51
Volume22.2K
Avg Volume10.0K
Share Statistics
Shares Outstanding
Employees27
ExchangeXNAS
Listed2017-11-03
Share count as of March 31, 2026
Loading Income Statement…
Key questions about Akso Health Group ADS (AHG)
What is Akso Health Group ADS's Market Cap?
Akso Health Group ADS's Market Cap is $2.1B, based on as-reported figures from SEC (XBRL) filings.
What is Akso Health Group ADS's Price / Sales?
Akso Health Group ADS's Price / Sales is 141.4×, based on as-reported figures from SEC (XBRL) filings.
What is Akso Health Group ADS's Revenue (TTM)?
Akso Health Group ADS's Revenue (TTM) is $14.8M, based on as-reported figures from SEC (XBRL) filings.
What is Akso Health Group ADS's Net Income (TTM)?
Akso Health Group ADS's Net Income (TTM) is -$135.7M, based on as-reported figures from SEC (XBRL) filings.
What is Akso Health Group ADS's EBITDA?
Akso Health Group ADS's EBITDA is -$163.8M, based on as-reported figures from SEC (XBRL) filings.
What is Akso Health Group ADS's Diluted EPS (TTM)?
Akso Health Group ADS's Diluted EPS (TTM) is -0.05, based on as-reported figures from SEC (XBRL) filings.
What is Akso Health Group ADS's EBITDA Margin?
Akso Health Group ADS's EBITDA Margin is -1103.9%, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemMar 31, 2026Mar 31, 2025Mar 31, 2024Mar 31, 2023Mar 31, 2022Mar 31, 2021Mar 31, 2020Mar 31, 2019Mar 31, 2018
REVENUES
Net Revenues
YoY growth-6.4%
Cost of revenue
Gross Profit
% of revenue-0.1%
OPERATING EXPENSE
Sales and marketing—
General and administrative
Impairment of goodwill and intangible assets
Total Operating Expenses
% of revenue149.6%
LOSS FROM CONTINUING OPERATIONS
% of revenue-149.7%
OTHER (EXPENSE) INCOME
Other income
Other expense
Exchange gain (loss)
Total Other (Expense) Income, net
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
(BENEFIT) PROVISON FOR INCOME TAXES
NET LOSS FROM CONTINUING OPERATIONS
NET LOSS
% of revenue-135.3%
Less: net loss attributable to non-controlling interest
NET LOSS ATTRIBUTABLE TO AKSO’S SHAREHOLDERS
% of revenue-135.0%
NET LOSS
% of revenue-135.3%
Less: comprehensive loss attributable to non-controlling interest
COMPREHENSIVE LOSS ATTRIBUTABLE TO AKSO’S SHAREHOLDERS
Basic (in Dollars per share)
Diluted (in Dollars per share)